Navigation Links
PharmAthene and Medarex Announce Additional $0.8 Million U.S. Government Appropriation for Continued Development of Anthrax Therapeutic Valortim(TM)
Date:11/6/2007

thrax models," said Dr. Meldorf. "The newly-developed USAMRIID model uses a rapidly detectable surrogate marker for the development of symptomatic anthrax disease. This will enable us to more accurately determine the therapeutic efficacy of Valortim in animals who have active disease defined in this way."

"Six years after the anthrax attacks of 2001, we believe that the development of effective therapies to prevent and treat anthrax infection is still a critical national security priority," said David P. Wright, President and Chief Executive Officer of PharmAthene. "Based on the promising preclinical and clinical data generated to date, we strongly believe that Valortim(TM) may be an appropriate choice for procurement in the Strategic National Stockpile under Project BioShield."

"We are pleased with the ongoing success of our colleagues at PharmAthene in securing external funding to support the advanced development of Valortim and believe that the new animal model under development at USAMRIID will help assess the therapeutic potency of this antibody," said Israel Lowy, M.D., Ph.D., Senior Director of Infectious Disease for Medarex. "Through our research we have identified important characteristics of Valortim, such as its mechanism of action, pharmacokinetics, animal efficacy, and favorable human safety data. We believe that these attributes will play a key role in the further development of Valortim and potential government procurement."

About Valortim

Valortim (MDX-1303) is a fully human antibody designed to protect against anthrax infection, including inhalation anthrax, the most lethal form of illness in humans caused by the Bacillus anthracis bacterium. The investigational antibody is designed to target a protein component known as the anthrax protective antigen (PA) of the lethal toxin complex produced by the bacterium. The anthrax protective antigen is believed to initiate the onset of the illness by attaching to cells in the infected
'/>"/>

SOURCE PharmAthene, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. PharmAthene to Present at the Rodman and Renshaw/Acumen BioFin 9th Annual Healthcare Conference
2. Ono and Medarex Announce Allowance of Investigational New Drug Application for Fully Human Anti-PD1 Antibody
3. Medarex to Present at the JPMorgan Small/Mid Cap Conference
4. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
5. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
6. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
7. HEI, Inc. Announces Sale of RFID Division Assets
8. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
9. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
10. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
11. Brooke Franchise Corporation Announces Selected July Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... South Asians living in Canada have a higher rate ... compared with while people, McMaster researchers have found. ... Canadian Medical Association Journal (CMAJ Open) and may ... the fastest-growing ethnic groups in the country is the ... Canada, comprising about three percent of the population. They ...
(Date:9/22/2014)... -- Recent two-generation approaches to reducing poverty that ... attention from researchers, advocates, and foundations. By combining ... to move to jobs that offer a path ... education for children, these programs aim to improve ... to a new report from the National Center ...
(Date:9/22/2014)... UK (PRWEB) September 22, 2014 The ... in the recent years. The statistically important data received ... safety of cancer vaccines. The primary challenge to the ... information about the exact mechanism of how a human’s ... to various results in different individuals owing to known ...
(Date:9/22/2014)... MONDAY, Sept. 22, 2014 (HealthDay News) -- Scans ... they learn to read. This finding could potentially ... other reading difficulties early on, preliminary research suggests. ... in children with dyslexia as well as most ... Hoeft, an associate professor of child and adolescent ...
(Date:9/22/2014)... (PRWEB) September 22, 2014 CareFlight ... has taken delivery of a new AS365 N3+ Dauphin, ... helicopter. The new aircraft, which is based at ... all-Dauphin fleet of four air medical transport helicopters. , ... said Candy Skidmore, Premier Health Vice President, Emergency, Trauma, ...
Breaking Medicine News(10 mins):Health News:Higher risk of heart disease for South Asians in Canada 2Health News:A two-generation lens: Current state policies fail to support families with young children 2Health News:World Cancer Vaccines Market Landscape Examined by Kuick Research in New Study Published at MarketPublishers.com 2Health News:World Cancer Vaccines Market Landscape Examined by Kuick Research in New Study Published at MarketPublishers.com 3Health News:World Cancer Vaccines Market Landscape Examined by Kuick Research in New Study Published at MarketPublishers.com 4Health News:Can Brain Scans Help Predict Young Children's Reading Abilities? 2Health News:Miami Valley Hospital CareFlight begins Service with AS365 N3+ 2Health News:Miami Valley Hospital CareFlight begins Service with AS365 N3+ 3
... 24 Catholic Charities,USA today urged Congress and ... come together to pass a comprehensive children,s health,insurance ... to vote on a compromise bill to,reauthorize the ... program that provides health insurance coverage to poor,children. ...
... and S.E.VEN, BOSTON, Sept. 24 Small Army, ... a cure for diabetes and,alleviating world poverty to their ... and S.E.VEN. "As communicators, we welcome the challenge ... dollars, but by a commitment,to truly make the world ...
... to Execute and Completeness of Vision, ANDOVER, ... management (IAM) solutions are the most widely implemented ... in the Visionaries,quadrant by Gartner, Inc. in the ... of the Magic Quadrant for User Provisioning, 2H07,(authored ...
... a,leading technology provider of mobile enterprise solutions for ... NASDAQ Stock,Market LLC has approved its application for ... Capital Market. Trading in the Company,s common stock,commenced ... the symbol "IFLG." (Logo: http://www.newscom.com/cgi-bin/prnh/20060209/PHTH052LOGO ...
... CHASKA, Minn., Sept. 24 Tired? Stressed? ... restore, and rejuvenate? The Village Company,( http://www.thevillagecompany.com ... bath,and body products, announces the nationwide launch ... relief from common ailments,( http://www.thevillagecompany.com/vntherapy.html ). ...
... Novo Nordisk, a,world leader in diabetes care, ... the Dow Jones Sustainability World Index (DJSI World) ... 18 global supersectors,analyzed. The latest global analysis ... analysis of companies, economic, environmental and,social performance, assessing ...
Cached Medicine News:Health News:Catholic Charities USA Calls on Congress and the President to Protect the Health of Children; Urges President Not to Veto Vitally Important Bill 2Health News:Catholic Charities USA Calls on Congress and the President to Protect the Health of Children; Urges President Not to Veto Vitally Important Bill 3Health News:Small Army Takes on Cure for Diabetes and New Approach to Ending World Poverty with Addition of Non-Profit Accounts 2Health News:Sentillion Positioned in Visionaries Quadrant in Leading Industry Analyst Firm's User Provisioning Magic Quadrant 2Health News:Sentillion Positioned in Visionaries Quadrant in Leading Industry Analyst Firm's User Provisioning Magic Quadrant 3Health News:InfoLogix Announces Approval for NASDAQ Listing 2Health News:InfoLogix Announces Approval for NASDAQ Listing 3Health News:The Village Company Unveils Natural Bath and Body Solutions for Everyday Ailments 2Health News:Novo Nordisk Ranks Supersector Leader in the 2007 Dow Jones Sustainability Indexes 2
(Date:9/22/2014)... 22, 2014 Research and Markets  has ... Neurotechnology: 2014-2018" report to their offering. ... most comprehensive and up-to-date publication available covering the neurotechnology ... technology, markets, competitors, and growth rates in four key ... through 2018. It forecasts the number of systems to ...
(Date:9/22/2014)... Sept. 22, 2014 Research and Markets ... and Other Novel Hypercholesterolemia Drugs" report to their ... is a high cholesterol burden despite the presence of ... the available options, statins have been ubiquitously prescribed over ... of plasma LDL cholesterol (LDLC) is the cornerstone of ...
(Date:9/22/2014)... , September 22, 2014 Persistence ... on "Global Market Study on Ophthalmic Devices: ... the global ophthalmic devices market was valued at USD 29,171.5 million ... CAGR of 6.5% from 2014 to 2020, to reach ... Browse the full Global Market Study on Ophthalmic ...
Breaking Medicine Technology:The Market for Neurotechnology: 2014-2018 2PCSK9 and Other Novel Hypercholesterolemia Drugs 2PCSK9 and Other Novel Hypercholesterolemia Drugs 3Global Ophthalmic Devices Market will Reach $2,685.1 Million in 2020: Persistence Market Research 2Global Ophthalmic Devices Market will Reach $2,685.1 Million in 2020: Persistence Market Research 3Global Ophthalmic Devices Market will Reach $2,685.1 Million in 2020: Persistence Market Research 4Global Ophthalmic Devices Market will Reach $2,685.1 Million in 2020: Persistence Market Research 5
... , COCKEYSVILLE, Maryland, November 2 ... Iron Phosphate Technology,to New Levels. , ... high-tech,batteries for industry, has expanded its range of lithium technologies ... phosphate,cell on the market. These large cells are designed for ...
... Shire plc (LSE: SHP, Nasdaq: SHPGY ... a major medical meeting from a Phase IIIb study of ... (methylphenidate transdermal system) in adolescents aged 13 to 17 years ... In addition, data regarding the pharmacokinetic profile of Daytrana in ...
Cached Medicine Technology:Saft Develops Super-Phosphate(TM) Technology for Rigorous Defense Applications 2Shire Reports Tolerability and Clinical Effects Results of Daytrana(R) (methylphenidate transdermal system) from Study in Adolescents with ADHD 2Shire Reports Tolerability and Clinical Effects Results of Daytrana(R) (methylphenidate transdermal system) from Study in Adolescents with ADHD 3Shire Reports Tolerability and Clinical Effects Results of Daytrana(R) (methylphenidate transdermal system) from Study in Adolescents with ADHD 4Shire Reports Tolerability and Clinical Effects Results of Daytrana(R) (methylphenidate transdermal system) from Study in Adolescents with ADHD 5Shire Reports Tolerability and Clinical Effects Results of Daytrana(R) (methylphenidate transdermal system) from Study in Adolescents with ADHD 6Shire Reports Tolerability and Clinical Effects Results of Daytrana(R) (methylphenidate transdermal system) from Study in Adolescents with ADHD 7
... of fibre bronchoscopy: The HF-compatible V series ... other fibre bronchoscopes are measured., ,The ... including the FB-19TV, FB-18V and FB-15V models ... the pediatric FB-8V, offer much better image ...
... High performance fiberoptic imaging from ... ,Olympus has improved its fiberscope range, ... specifications and enhanced image performance. Olympus ... instruments for diagnosis and therapy in ...
... performance fiberoptic imaging from the latest ... improved its fiberscope range, focussing on ... enhanced image performance. Olympus has a ... diagnosis and therapy in the respiratory ...
Slim bronchoscope designed for paediatric applications....
Medicine Products: